Bcl-2-IN-11 structure
|
Common Name | Bcl-2-IN-11 | ||
---|---|---|---|---|
CAS Number | 2760536-88-5 | Molecular Weight | 902.43 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C45H49ClFN7O8S | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Bcl-2-IN-11Bcl-2-IN-11 (compound 6) is a potent and selective Bcl-2 activity inhibitor, with an IC50 of 0.9 nM. Bcl-2-IN-11 shows weak inhibition of Bcl-xl (IC50 > 1000 nM). Bcl-2-IN-11 can be used for the research of a variety of cancers caused by abnormal overexpression of Bcl-2 family proteins: especially malignant hematologic diseases of acute lymphoid leukemia, etc. Bcl-2-IN-11 can also avoid toxic side effects caused by Bcl-xl inhibition, such as thrombocytopenia[1]. |
Name | Bcl-2-IN-11 |
---|
Description | Bcl-2-IN-11 (compound 6) is a potent and selective Bcl-2 activity inhibitor, with an IC50 of 0.9 nM. Bcl-2-IN-11 shows weak inhibition of Bcl-xl (IC50 > 1000 nM). Bcl-2-IN-11 can be used for the research of a variety of cancers caused by abnormal overexpression of Bcl-2 family proteins: especially malignant hematologic diseases of acute lymphoid leukemia, etc. Bcl-2-IN-11 can also avoid toxic side effects caused by Bcl-xl inhibition, such as thrombocytopenia[1]. |
---|---|
Related Catalog | |
Target |
Bcl-2:0.9 nM (IC50) Bcl-xL:>1000 nM (IC50) |
References |
[1]. Kong Xianglong, et al. Heterocyclic compound as bcl-2 inhibitor. WO2022028353A1. |
Molecular Formula | C45H49ClFN7O8S |
---|---|
Molecular Weight | 902.43 |